Effect of PPAR-γ Agonist Rosiglitazone on Bone Mineral Density and Serum Adipokines in C57BL/6 Male Mice Cited by

Fol. Biol. 2011, 57, 133-138

https://doi.org/10.14712/fb2011057040133

Effect of PPAR-γ Agonist Rosiglitazone on Bone Mineral Density and Serum Adipokines in C57BL/6 Male Mice

Petr Dan Broulík¹, L. Šefc², M. Haluzík¹

¹Third Department of Medicine – Department of Endocrinology and Metabolism, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic
²Institute of Pathological Physiology and Centre for Experimental Haematology, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic

Received January 2011
Accepted February 2011

Crossref Cited-by Linking

Yu Wei-wei, Xia Qin, Wu Yan, Bu Qiao-yun: Activation of PPAR-\u03b3 inhibits differentiation of rat osteoblasts by reducing expression of connective tissue growth factor. J. Huazhong Univ. Sci. Technol. [Med. Sci.] 2014, 34, 652. <https://doi.org/10.1007/s11596-014-1332-y>
Schwartz Ann V., Vittinghoff Eric, Margolis Karen L., Scibora Lesley M., Palermo Lisa, Ambrosius Walter T., Hue Trisha F., Ensrud Kristine E.: Intensive Glycemic Control and Thiazolidinedione Use: Effects on Cortical and Trabecular Bone at the Radius and Tibia. Calcif Tissue Int 2013, 92, 477. <https://doi.org/10.1007/s00223-013-9703-0>